SUNRISE, Fla., Jan. 22, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT), a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, today announced that Chairman, CTO and CEO, Howard Leonhardt, will present its corporate presentation at the Cell & Gene Therapy Forum 2009 in Washington, D.C., on Tuesday, January 27th at 2:30 p.m.
